Quantbot Technologies LP Intra Cellular Therapies, Inc. Transaction History

Quantbot Technologies LP

$2.36 Billion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	BUY	$64.76 - $79.84 $244,922 - $301,954	3,782 New	3,782 $259,000
Q3 2023 Nov 07, 2023	BUY	$52.09 - $64.1 $101,367 - $124,738	1,946 Added 22.48%	10,602 $552,000
Q2 2023 Aug 08, 2023	SELL	$54.67 - $66.44 $111,417 - $135,404	-2,038 Reduced 19.06%	8,656 $548,000
Q1 2023 May 12, 2023	BUY	$43.8 - $56.99 $468,397 - $609,451	10,694 New	10,694 $579,000
Q3 2022 Nov 07, 2022	BUY	$42.7 - $59.99 $50,770 - $71,328	1,189 New	1,189 $55,000
Q1 2022 May 16, 2022	SELL	$38.74 - $62.09 $447,601 - $717,387	-11,554 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$35.2 - $53.42 $406,700 - $617,214	11,554 New	11,554 $604,000
Q4 2020 Feb 12, 2021	SELL	$23.34 - $32.22 $32,465 - $44,818	-1,391 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$17.61 - $31.86 $24,495 - $44,317	1,391 New	1,391 $35,000
Q4 2019 Feb 10, 2020	SELL	$7.26 - $38.49 $95,643 - $507,067	-13,174 Closed	0 $0
Q3 2019 Nov 12, 2019	BUY	$7.47 - $14.03 $98,409 - $184,831	13,174 New	13,174 $98,000
Q1 2019 May 13, 2019	SELL	$10.9 - $14.09 $7,379 - $9,538	-677 Closed	0 $0
Q4 2018 Feb 13, 2019	SELL	$10.36 - $20.96 $40,735 - $82,414	-3,932 Reduced 85.31%	677 $7,000
Q3 2018 Nov 13, 2018	BUY	$17.77 - $22.9 $80,444 - $103,668	4,527 Added 5520.73%	4,609 $100,000
Q2 2018 Aug 13, 2018	SELL	$17.33 - $23.4 $97,325 - $131,414	-5,616 Reduced 98.56%	82 $1,000
Q1 2018 May 11, 2018	BUY	$15.16 - $25.49 $32,806 - $55,160	2,164 Added 61.23%	5,698 $119,000
Q4 2017 Feb 12, 2018	SELL	$14.27 - $16.79 $72,491 - $85,293	-5,080 Reduced 58.97%	3,534 $51,000
Q3 2017 Nov 07, 2017	BUY	$10.77 - $22.1 $92,772 - $190,369	8,614	8,614 $135,000

Others Institutions Holding ITCI

# of Institutions

378

Shares Held

84.7M

Call Options Held

319K

Put Options Held

143K

Vanguard Group Inc Valley Forge, PA

9.63M
Shares

$800 Million
0.01% of portfolio
Black Rock Inc. New York, NY

6.32M
Shares

$525 Million
0.01% of portfolio
Jpmorgan Chase & CO New York, NY

5.29M
Shares

$439 Million
0.03% of portfolio
Wasatch Advisors Inc Salt Lake City, UT

3.85M
Shares

$320 Million
1.4% of portfolio
Avoro Capital Advisors LLC New York, NY

3.05M
Shares

$253 Million
3.36% of portfolio

View Full List

About Intra-Cellular Therapies, Inc.

Ticker ITCI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 94,401,696
Market Cap $7.85B
Description
Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...

More about ITCI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Quantbot Technologies LP, based on Form 13F filings with the SEC.

News

Stay updated on Quantbot Technologies LP with notifications on news.

Account